SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-272852
Filing Date
2020-10-20
Accepted
2020-10-20 16:03:29
Documents
3
Period of Report
2020-10-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d46540d8k.htm 8-K 21172
2 EX-3.1 d46540dex31.htm EX-3.1 52654
3 EX-3.2 d46540dex32.htm EX-3.2 164895
  Complete submission text file 0001193125-20-272852.txt   239932
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39617 | Film No.: 201248316
SIC: 2836 Biological Products, (No Diagnostic Substances)